David Thompson, Purdue University (IMAGE)
Caption
Purdue University researcher David Thompson has developed LENN, a system to deliver nucleic acid-based therapies to targeted cancer cells. His and his team’s research into using LENN to deliver therapies to bladder cancer cells has been published in the peer-reviewed journal Biomacromolecules.
Credit
(Purdue Agricultural Communications photo/Tom Campbell)
Usage Restrictions
None
License
Original content